Boscalid

DB12792ApprovedWithdrawnSmall molecule

Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.

Chemical structure of Boscalid
Mechanism
Curator reviewed
Formula / weight
C18H12Cl2N2O · 343.207 g/mol (avg)
Also known as
Endura
Code names
BAS 510 F

Resolves to

Compound
UNII32MS8ZRD1VCAS188425-85-6ChEMBLCHEMBL1076544ChEBI81822PubChem213013KEGGC18547
Clinical / RWD
RxNorm1735163
Structure
InChIKeyWYEMLYFITZORAB-UHFFFAOYSA-NSMILESClC1=CC=C(C=C1)C1=C(NC(=O)C2=C(Cl)N=CC=C2)C=CC=C1

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Boscalid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In